Hypertrophic Cardiomyopathy, Sudden Death, ... your doctor may treat you with medications to prevent arrhythmias or with an ICD. Most people with HCM are at low risk for sudden cardiac death.

Within the study window, 23,535 adults were hospitalized with HCM, while 3954 (16.8%) underwent ICD implantations; the authors found an overall increasing trend in ICD use (11.6% in 2003 to 17% in ...

Chicago, IL - Only one guideline-defined risk factor for sudden cardiac death (SCD) can be enough to consider patients with hypertrophic cardiomyopathy (HCM) for a primary-prevention implantable ...

The ICD sports safety registry studied 328 patients (mean age 33 years) for ICD events over a median follow-up of 31 months and documented no deaths or resuscitated cardiac arrests.34 However, within ...

However, accurately selecting which HCM patients need this ICD device, which is implanted in the patient for their lifetime, has been challenging, and which methods to use have been debatable.

Targeted ICD selection based on predicted therapy benefit enhances patient outcomes while cutting hospital costs by 16.7%.

Hypertrophic cardiomyopathy (HCM), ... Selection of patients for prophylactic ICD placement is based on major markers of risk, sometimes in association with potential risk mediators.

Treatment for hypertrophic cardiomyopathy (HCM) starts with managing your symptoms with effective treatment. ... (ICD) in patients who have a higher chance of having sudden cardiac death. An ...

This guide will help you understand how HCM presents in children and how to support your child through diagnosis and treatment.

Hypertrophic cardiomyopathy is a condition in which your heart muscle is thicker than usual. It can interfere with your heart’s ability to pump blood. Learn more.

Identifying high-risk individuals with hypertrophic cardiomyopathy is paramount as the first clinical expression is often the most devastating—sudden cardiac death. Miller and colleagues review ...